VB-111: A novel anti-vascular therapeutic for glioblastoma multiforme

Lignende værker

• BMET-26 PHASE 2 STUDY OF VB-111, AN ANTI-CANCER GENE THERAPY, AS MONOTHERAPY FOLLOWED BY COMBINATION OF VB-111 WITH BEVACIZUMAB, IN PATIENTS WITH RECURRENT GLIOBLASTOMA
  af: Brenner, Andrew, et al.
  Udgivet: (2015)
• NT-07 PHASE 1-2 DOSE-ESCALATION STUDY OF VB-111, AN ANTI-ANGIOGENIC GENE THERAPY, AS MONOTHERAPY AND IN COMBINATION WITH BEVACIZUMAB, IN PATIENTS WITH RECURRENT GLIOBLASTOMA
  af: Brenner, Andrew, et al.
  Udgivet: (2014)
• ATIM-03. BIOMARKER ANALYSIS SUPPORTS THE VB-111 DUAL MECHANISM OF ACTION
  af: Gruslova, Aleksandra, et al.
  Udgivet: (2017)
• Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study
  af: Brenner, Andrew J, et al.
  Udgivet: (2020)
• Antitumor Activity of VB-111, a Novel Antiangiogenic Virotherapeutic, in Thyroid Cancer Xenograft Mouse Models
  af: Reddi, H. V., et al.
  Udgivet: (2011)